4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-24-118982
Chief Financial Officer sold 9,102 shares at an average $6.03 ($54,905)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-28 | Sale : show line 1 in the form 10b5-1 | −1,697 | $6.06 | $10,284 | 311,496 | D |
| 2024-10-28 | Sale : show line 2 in the form 10b5-1 | −5,105 | $6.06 | $30,936 | 306,391 | D |
| 2024-10-29 | Sale : show line 3 in the form 10b5-1 | −2,300 | $5.95 | $13,685 | 304,091 | D |
| Open-market sales · 9,102 sh · avg $6.03 · $54,905 | ||||||
Loading xslF345X05/ownership.xml…